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Background: An unfavorable trend of increasing rates of colorectal cancer has been observed across modern
societies. In general, dietary factors are understood to be responsible for up to 70% of the disease’s incidence,
though there are still many inconsistencies regarding the impact of specific dietary items. Among the dietary
minerals, calcium intake may play a crucial role in the prevention. The purpose of this study was to assess the effect
of intake of higher levels of dietary calcium on the risk of developing of colorectal cancer, and to evaluate dose
dependent effect and to investigate possible effect modification.
Methods: A hospital based case–control study of 1556 patients (703 histologically confirmed colon and rectal
incident cases and 853 hospital-based controls) was performed between 2000–2012 in Krakow, Poland. The 148-
item semi-quantitative Food Frequency Questionnaire to assess dietary habits and level of nutrients intake was
used. Data regarding possible covariates was also collected.
Results: After adjustment for age, gender, education, consumption of fruits, raw and cooked vegetables, fish, and
alcohol, as well as for intake of fiber, vitamin C, dietary iron, lifetime recreational physical activity, BMI, smoking status,
and taking mineral supplements, an increase in the consumption of calcium was associated with the decrease of colon
cancer risk (OR = 0.93, 95% CI: 0.89-0.98 for every 100 mg Ca/day increase). Subjects consumed >1000 mg/day showed
46% decrease of colon cancer risk (OR = 0.54, 95% CI: 0.35-0.83). The effect of dietary calcium was modified by dietary
fiber (p for interaction =0.015). Finally, consistent decrease of colon cancer risk was observed across increasing levels of
dietary calcium and fiber intake. These relationships were not proved for rectal cancer.
Conclusions: The study confirmed the effect of high doses of dietary calcium against the risk of colon cancer
development. This relationship was observed across different levels of dietary fiber, and the beneficial effect of dietary
calcium depended on the level of dietary fiber suggesting modification effect of calcium and fiber. Further efforts are
needed to confirm this association, and also across higher levels of dietary fiber intake.
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Despite the many public health interventions to prevent
the development of cancer - including colorectal cancer -
that have been undertaken during the last decades, in-
creasing prevalence of colorectal cancer across modern
societies is still observed. According to the WHO, colorec-
tal cancer amounts to approximately 1 234 000 new cases* Correspondence: aleksander.galas@uj.edu.pl
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reproduction in any medium, provided the orannually, and accounts for 608 000 deaths worldwide [1].
There is a large available body of published scholarship on
the role of diet in the development of this disease, though
it presents with numerous inconsistencies. Nevertheless, it
is accepted that dietary factors are responsible for up to
70% of colorectal cancer cases [2].
Calcium is a mineral that has been intensively investi-
gated in terms of its role in the prevention of colorectal
cancer. There are a fair amount of plausible biological
mechanisms (indirect and direct) explaining the physio-
logical role of calcium. The indirect pathway is expectedtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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complexes [3], thus decreasing the proliferative role of
secondary bile acids [4]. The direct pathway is associated
with the role of calcium played at the cellular level, and
this pathway is also related to the action of vitamin D, as
the effect of the intracellular concentration of calcium,
activation of calmodulin, phosphorylation of some cellu-
lar enzymes and activation of signaling pathways leading
to cell differentiation or apoptosis [5].
Despite the presence of a relatively good body of evi-
dence from basic research (meaning an experimental or
theoretical work undertaken primarily to acquire new
knowledge of the underlying foundations of phenomena
and observable facts, without any particular application
or use in view [6]), human studies haven’t shown con-
sistent results. Majority studies performed before the
year 2000 failed to confirm the presence of a clear bene-
ficial effect of calcium [7-10]. There have also been stud-
ies on the use of calcium supplements, showing an up to
34% reduction in a rate of colorectal adenoma re-
currence among patients with a history of adenomas
[11-13]. The results of most recent studies are also in-
consistent [14,15]. However, there is increasing evidence
suggesting that calcium plays a prophylactic role [16-18].
There are some possible explanations for the lack of an
observed benefit from calcium on the development of
colorectal cancer. One is the effect of dose, as some of the
investigations evaluated the risk across relatively low dos-
ages [19]; some others were not designed for that purpose
[14]; some had relatively small sample sizes [12,20,21]; and
finally, calcium - especially dietary calcium is one of sev-
eral dietary components, and analyses performed probably
did not enable researchers to isolate the effects of calcium
from the role of some other dietary nutrients.
The purpose of this study was to assess the role of in-
take of higher levels (over 1000 mg/day) of dietary cal-
cium on the risk of colorectal cancer, to evaluate dose
dependent effect. Besides, there is evidence in colon can-
cer research showing protective effect of fiber [18,22]
which is consumed in different food than calcium. This
has led us to the hypothesis that intake of fiber may
modify the effect of calcium.
Methods
Sample
This paper provides an analysis of three consecutive stages
of a hospital-based case control study carried out between
2000 and 2012 in Krakow. Cases chosen for this study
were of patients diagnosed and treated at the I Chair of
General Surgery and Department of Gastroenterological
Surgery, Jagiellonian University Medical College, Krakow,
Poland and controls were adults admitted to the I Depart-
ment of Internal Medicine Jagiellonian University Medical
College and to the II Internal Ward at the NarutowiczMunicipal Hospital in Krakow. The design of the study
has been described elsewhere [23,24]. In brief, study par-
ticipants were incident cases of colorectal cancer. All
included cases consisted of histologically confirmed spor-
adic adenocarcinomas of either the colon or rectum. Con-
trol group patients were recruited at the same time from
inpatients hospitalized due to other health problems.
Exclusion criteria consisted of the following: age over 75,
the presence of communication (verbal contact) problems
and/or cognitive limitations, and diagnosis of any of the
following: hereditary non-polyposis colorectal cancer, fa-
miliar adenomatous polyposis, attenuated familial aden-
omatous polyposis, mixed polyposis syndrome, Ashkenazi
colon cancer, hereditary breast and colorectal cancer or
any of hamartomatous polyposis syndrome, moreover, the
diagnosis of secondary cancer (distant metastasis), the
diagnosis of primary cancer other than colorectal, recur-
rent cancer, underwent surgery (before recruitment) of
gastrointestinal tract, present or past diagnosis of chronic
disease of gastrointestinal tract (diverticulitis, irritable
bowel syndrome, acute or chronic gastric ulcer, acute/
chronic pancreatitis), diabetes (any type), renal failure,
hepatic insufficiency or the presence of prolonged gastro-
intestinal symptoms.
Tools and data collection
Study participants were recruited at the time of their hos-
pital admission. After written consent had been obtained,
data was collected by trained interviewers during a face-
to-face interview. A standardized questionnaire included
questions about socio-demographic characteristic, dietary
habits, alcohol consumption, smoking, physical activity
and some other health behaviors. The design of the study
was approved by the Bioethical Committee of Jagiellonian
University, Krakow, Poland.
Dietary habits were evaluated by administration of a
semi-quantitative food frequency questionnaire (SFFQ).
The SFFQ was designed and developed with the cooper-
ation with the German Cancer Research Centre while the
tool development part of the EPIC-project (European
Prospective Investigation into Cancer and Nutrition) was
performed. In total, 148-dietary items were used in the
SFFQ including questions about consumption of cereals,
dairy products, bread, type and cuts of meat and fish (in-
cluding preparation technique), fresh fruits (summer/win-
ter time), salads and fresh and cooked vegetables, rice or
pasta, soups, sweets, baked goods, drinks and others.
For each food or beverage item, a commonly consumed
portion size was specified by standardized photographs.
Next, respondents were asked to provide information
about frequency of consumption. For the research infor-
mation about usual (habitual) consumption over the
period of 1 year by calendar seasons was gathered by
trained interviewers. Patient-cases were asked about their
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gastrointestinal symptoms (if were present) or prior to the
beginning of the diagnosis process. Control patients were
asked about their usual diet 5 years before the interview.
The Polish food composition tables were used to calculate
the intake of macro and micronutrients [25,26]. The valid-
ity and reproducibility of the questionnaire was assessed
and published elsewhere [27,28].
Covariates
The protocol enabled collection of information about pos-
sible covariates. Physical activity from recreational activ-
ities was assessed over adult lifetime starting from age 20
through 30, 40, 50 and 60 years of age. Participants
reported the average weekly time spent on 5 groups of ac-
tivities: walking or hiking, bicycling, gardening, practicing
sports and household activities, separately for summer
and winter times. Additionally, they were asked about the
amount of time spent on recreational activities which re-
quired at least moderate effort. Finally, the reported time
spent on each activity was multiplied by its typical energy
expenditure requirements according to 2011 Compen-
dium of Physical Activities [29]. Because respondents rep-
orted total time spent on activities and didn’t consider
brakes and a time within which they were able to reach
the required level of effort, it was considered that 70% of
reported time was spent effectively and these results were
finally presented and used in the analyses. There were also
some other covariates used, such as age, education, num-
ber of portions of fruits and raw and cooked vegetables
consumed daily and of fish consumption weekly, alcohol
consumption, vitamin C, Body Mass Index (in kg/m2),
smoking (current, ex-smoker, non-smoker), taking mineral
supplements and dietary iron (as a proxy measure of meat
consumption).
Statistical analysis
Groups were characterized by providing statistical mean
and standard deviations as well as median with inter
quartile range. The distributions of continuous variables
were skewed (as tested by the Shapiro-Wilk test). To es-
timate statistical significance for the difference between
groups the Mann–Whitney test was used. For categor-
ical variables, significance was assessed by the chi-square
test. The relative risk of the development of colorectal
cancer as well as for colon and rectal cancers related to
the different levels of dietary item intake was estimated
by the odds ratios calculated by multivariable logistic re-
gression models. Three major models were analyzed.
One was used to estimate the effect of linear increase in
consumption of calcium by 100 mg, the second to assess
linear increase by 1000 mg and the third investigated the
effect by categories meaning that the group of individ-
uals consumed over 1000 mg dietary calcium per daywas compared with the group who consumed less.
Moreover, we performed analyzes considering three
main logistic regression models (unadjusted; adjusted for
demographic variables: age, gender, education; and fully
adjusted model: adjusted for age, gender, education [pri-
mary school or less, vocational school, secondary/high
school, university or higher], fish consumption [serv-
ings/week], fruit, raw and cooked vegetable consumption
[servings/day], fiber [g/day], vitamin C [mg/day], dietary
iron [<=14,03 mg/day; >14,03 mg/day], alcohol con-
sumption [g/week], adult lifetime recreational physical
activity [METs-h/week], BMI [kg/m2], smoking [current,
ex-smokers, non-smokers], taking mineral supplements
[yes/no]) for the whole group of colorectal cancer cases,
as well as separately for colon and rectal cancers. Subse-
quently, an effect modification by calcium intake in the re-
lationship between fiber consumption and colorectal
cancer was investigated by testing an interaction term. Fi-
nally, sub-group differences considering the presence of
interaction were analyzed. The effmod procedure (Stata
Corp software) was used for this purpose. The effmod cal-
culates user specified stratum specific odds ratios and con-
fidence intervals for logistic regression models which
include interaction terms between an exposure and effect
modifiers. For missing data the pairwise deletion proced-
ure was used. The statistical software package Stata/IC
11.2 for Windows, Stata Corp LP was used. The ‘p’ value
below 0.05 was considered statistically significant.
Results
During the period 2000–2012, 703 colorectal cancer cases
and 853 controls were recruited for the study. There were
341 (48.5%) colon and 362 (51.5%) rectal adenocarcin-
omas. Among controls, there were disorders of thyroid
gland (E00-E07: 3.8%, mainly E04 ‘other nontoxic goiter’),
hypertensive diseases (I10-I15: 11.7%, mainly I10 ‘primary
hypertension’), ischemic heart disease (I20-I24: 19.7%,
mainly I20 ‘angina pectoris’), other forms of heart disease
(I30-I52: 3.9%, mainly I48 ‘atrial fibrillation and flutter’),
diseases of respiratory system (J00-J99: 7.7%, mainly J18
‘pneumonia’), hernia (K40-K46: 11.3%, mainly K40 ‘in-
guinal hernia’), disorders of gallbladder (K80-K87: 21.6%,
mainly K80 ‘cholelithiasis’), syncope and collapse (R55:
2.1%), injuries (S00-S99: 4.7%, mainly S80-S89 ‘injuries to
knee and lower leg’) and others (13.7%).
Basic characteristic of the study sample was presented
in Table 1. Among colorectal cancer cases as compared
to controls, there were more males (56.6% vs. 51.5%),
cases were older (57.9 vs. 54.8 yrs) and there were less
ex-smokers (25.5% vs. 31.3%) and more non-smokers
(30.6% vs. 24.2%).
Regarding foods and dietary items, we analyzed only
those, which were considered as potential covariates. It
was observed that colorectal cancer patients consumed
Table 1 Basic characteristic of study participants
Colorectal cancer cases Controls p
[n = 703] [n = 853]
Gender [n, (%)]
Males 398 (56.6%) 439 (51.5%) df = 1
Females 305 (43.4%) 414 (48.5%) pchi = 0.043
Age
Mean, (SD) 57.9 (9.1) 54.8 (11.5)
Median (Q1-Q3) 59 (52–65) 56 (47–64) pMW < 0.001
Education [n, (%)] n = 701 n = 852
Primary school or less 106 (15.1%) 126 (14.8%) df = 3
Vocational school 185 (26.4%) 236 (27.7%) pchi = 0.947
Secondary/high school 250 (35.7%) 296 (34.7%)
University or higher 160 (22.8%) 194 (22.8%)
Recreational physical activity* [METs-h/week]
Mean, (SD) 17.3 (16.0) 17.0 (15.4) pMW = 0.968
Median (Q1-Q3) 12.9 (5.6-24.5) 13.0 (5.8-24.4)
BMI/body mass index [kg/m2] n = 702 n = 846
Mean, (SD) 27.3 (4.1) 27.2 (4.6) pMW = 0.411
Median (Q1-Q3) 26.9 (24.4-29.7) 26.7 (24.1-29.8)
Smoking n = 852
Current smoker 309 (43.9%) 379 (44.5%) df = 2
Ex-smoker 179 (25.5%) 267 (31.3%) pchi = 0.005
Non-smoker 215 (30.6%) 206 (24.2%)
chi-chi-square test; df degrees of freedom, MW Mann–Whitney test.
* -adult lifetime recreational physical activity, i.e. the average for the period 18-current age (if current age <66) or for the period 18–65 (if current age >65).
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cium and dietary iron (Table 2).
The main aim of the study was to analyze the role of
dietary calcium intake in the development of colorec-
tal cancer. An increase of dietary calcium intake by
100 mg/day was associated with 5% decrease of colorectal
cancer risk (OR = 0.95, 95% CI: 0.92-0.99), and this was sig-
nificant also after adjustment for several covariates (Model
3 in the Table 3). Analyses performed for colon and rectal
cancer separately, revealed that the effect of calcium was
even greater for colon (OR = 0.93; 95% CI: 0.89-0.98) but
was not observed for rectal cancer. Similar tendency
was observed in the analyses investigating the effect of
1000 mg calcium/day increase. The cancer risk was signifi-
cantly decreased by 37% for colorectal cancer, and by 50%
for colon cancer, but was not significant for rectal cancer.
The effect of higher against lower level of dietary calcium
was also analyzed. It was found that higher (>1000 mg/
day) dietary calcium was associated with 30% (OR = 0.70,
95% CI: 0.51-0.96) decrease of colorectal cancer (in gen-
eral) and with 46% (OR = 0.54; 95% CI: 0.35-0.83) decrease
of colon cancer risk. Our investigation failed to show an as-
sociation with rectal cancer (Table 3). Additional analy-
ses considering the effect of smaller amounts of dietarycalcium didn’t show the positive effect across categories of
less than 1000 mg/day.
The second aim of our investigation was to verify the hy-
pothesis that the protective effect of calcium depends on
the level of fiber intake. The interaction between dietary
calcium (>1000 mg/day; <=1000 mg/day) and fiber (con-
tinuous) was statistically significant considering all colorec-
tal cancer cases (p for interaction in the full multivariable
logistic regression model = 0.003) as well as colon cancer
cases (p for interaction in the full model = 0.015). When
rectal cancer cases were tested, p for interaction was insig-
nificant (p for interaction in the full model = 0.062).
As a next step we investigated the effect of dietary cal-
cium across different categories of fiber consumption. It
was revealed that among individuals who consumed less
fiber (<6 g/day) the effect of calcium was lower and sta-
tistically insignificant. Contrarily, those who consumed
more fiber had stronger calcium associated decrease of
colorectal and (when considered cancer site) colon can-
cer risk. This was not proven for rectal cancer (Table 3).
Finally, we analyzed the risk of colorectal, colon and
rectal cancer across different levels (categories) of fiber
intake and potential effect modification by the intake of
dietary calcium. It was observed decreased risk with the
Table 2 Intake of main dietary items
Colorectal cancer cases Controls p
[n = 703] [n = 853]
Fish consumption [servings/week]
Mean (SD) 1.2 (1.2) 1.4 (1.4) pMW = 0.040
Median (Q1-Q3) 0.9 (0.5-1.5) 1.1 (0.6-1.8)
Fruits [servings/day]
Mean (SD) 1.8 (1.6) 2.3 (3.1)
Median (Q1-Q3) 1.3 (0.7-2.5) 1.4 (0.7-3.0) pMW = 0.340
Raw vegetables [servings/day]
Mean (SD) 1.2 (0.8) 1.3 (1.3)
Median (Q1-Q3) 1.0 (0.6-1.5) 0.9 (0.6-1.6) pMW = 0.932
Cooked vegetables [servings/day]
Mean (SD) 0.5 (0.3) 0.6 (0.3)
Median (Q1-Q3) 0.5 (0.3-0.7) 0.5 (0.4-0.7) pMW = 0.135
Total energy [kcal/day]
Mean (SD) 2236 (771) 2407 (1035)
Median (Q1-Q3) 2088 (1725–2558) 2152 (1669–2857) pMW = 0.090
Pure alcohol [g/week]
Mean (SD) 33.4 (67.0) 34.3 (102.9)
Median (Q1-Q3) 8.3 (2.8-33.2) 5.2 (2.4-27.2) pMW = 0.013
Fiber [g/d]
Mean (SD) 4.5 (1.6) 4.7 (2.0)
Median (Q1-Q3) 4.2 (3.4-5.4) 4.2 (3.3-5.7) pMW = 0.981
Vitamin C [mg/d]
Mean (SD) 93.1 (50.9) 99.4 (62.4)
Median (Q1-Q3) 78.7 (57.9-117.6) 81.6 (55.2-129.5) pMW = 0.464
Calcium [g/d]
Mean (SD) 0.72 (0.30) 0.79 (0.41)
Median (Q1-Q3) 0.65 (0.50-0.86) 0.69 (0.50-0.93) pMW = 0.025
Dietary iron [mg/d]
Mean (SD) 14.5 (4.9) 15.7 (6.7)
Median (Q1-Q3) 13.6 (11.2-16.7) 14.0 (11.1-18.2) pMW = 0.036
Taking mineral supplements df = 1
[n, (%)] 121 (14.2%) 105 (14.9%) pchi = 0.676
MW Mann–Whitney test, df degrees of freedom; chi-chi-square test.
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with the greatest risk reduction for the highest level of cal-
cium and fiber intake (OR = 0.23). Similar pattern was
observed for colon cancer, however estimates in the
subgroup consuming the lowest amount of calcium
(<1000 mg/day) were insignificant. Analysis performed for
rectal cancer failed to show significant results (Table 4).
Discussion
Our study supports evidence showing the protective ef-
fect of calcium in the development of colorectal cancer.It has been investigated the effect of high doses (over
1000 mg/day) of dietary calcium. In general our findings
suggest the presence of a relationship for colon cancer
and failed for rectal cancer, what is consistent with some
other published results [30,31]. Our study has proved
the positive effect showing about 7% decrease in the risk
of developing colon cancer for every 100 mg/day in-
crease of dietary calcium, and more than 40% decrease
among these who consumed more than 1000 mg/day as
compared to lower consumption level. Moreover our in-
vestigation suggests the presence of interaction between
Table 3 Calcium intake and odds ratio for colorectal cancer, colon cancer and rectal cancer
Dietary calcium Model 1 Model 2 Model 3
OR 95% CI P OR 95% CI P OR 95% CI P
Colorectal cancer
For 100 mg/day increase 0.95 0.92-0.98 <0.001 0.95 0.92-0.98 0.001 0.95 0.92-0.99 0.014
For 1000 mg/day increase 0.58 0.44-0.78 <0.001 0.61 0.45-0.82 0.001 0.63 0.44-0.91 0.014
<= 1000 mg/day 1 (ref.) 1 (ref.) 1 (ref.)
>1000 mg/day 0.65 0.50-0.85 0.002 0.66 0.50-0.87 0.003 0.70 0.51-0.96 0.025
Dietary fiber <6 g/day
For 100 mg/day increase 0.97 0.94-1.01 0.174 0.98 0.95-1.02 0.411 0.96 0.92-1.01 0.093
For 1000 mg/day increase 0.78 0.54-1.12 0.174 0.86 0.59-1.24 0.411 0.69 0.44-1.06 0.093
<= 1000 mg/day 1 (ref.) 1 (ref.) 1 (ref.)
>1000 mg/day 0.85 0.60-1.23 0.409 0.91 0.63-1.32 0.628 0.87 0.59-1.30 0.508
Dietary fiber > =6 g/day
For 100 mg/day increase 0.91 0.85-0.97 0.003 0.91 0.85-0.97 0.005 0.91 0.84-0.98 0.013
For 1000 mg/day increase 0.38 0.20-0.73 0.003 0.39 0.20-0.76 0.005 0.38 0.18-0.81 0.013
<= 1000 mg/day 1 (ref.) 1 (ref.) 1 (ref.)
>1000 mg/day 0.54 0.33-0.87 0.011 0.54 0.33-0.88 0.013 0.48 0.27-0.85 0.012
Colon cancer
For 100 mg/day increase 0.95 0.91-0.98 0.004 0.95 0.91-0.98 0.006 0.93 0.89-0.98 0.007
For 1000 mg/day increase 0.58 0.40-0.84 0.004 0.58 0.40-0.85 0.006 0.50 0.31-0.83 0.007
<= 1000 mg/day 1 (ref.) 1 (ref.) 1 (ref.)
>1000 mg/day 0.58 0.40-0.83 0.003 0.59 0.41-0.85 0.005 0.54 0.35-0.83 0.005
Dietary fiber <6 g/day
For 100 mg/day increase 0.98 0.93-1.02 0.273 0.98 0.94-1.03 0.405 0.94 0.89-0.998 0.042
For 1000 mg/day increase 0.78 0.50-1.22 0.273 0.82 0.52-1.30 0.405 0.55 0.31-0.98 0.042
<= 1000 mg/day 1 (ref) 1 (ref) 1 (ref)
>1000 mg/day 0.76 0.47-1.22 0.248 0.82 0.50-1.34 0.428 0.72 0.43-1.23 0.232
Dietary fiber > =6 g/day
For 100 mg/day increase 0.90 0.83-0.98 0.014 0.90 0.82-0.98 0.020 0.88 0.79-0.98 0.022
For 1000 mg/day increase 0.34 0.15-0.81 0.014 0.33 0.13-0.84 0.020 0.28 0.10-0.83 0.022
<= 1000 mg/day 1 (ref) 1 (ref) 1 (ref)
>1000 mg/day 0.47 0.25-0.88 0.019 0.46 0.24-0.90 0.022 0.37 0.18-0.79 0.010
Rectal cancer
For 100 mg/day increase 0.95 0.92-0.99 0.006 0.96 0.92-0.99 0.016 0.97 0.93-1.02 0.233
For 1000 mg/day increase 0.61 0.43-0.87 0.006 0.65 0.45-0.92 0.016 0.77 0.49-1.19 0.233
<= 1000 mg/day 1 (ref) 1 (ref) 1 (ref)
>1000 mg/day 0.72 0.52-1.00 0.053 0.73 0.52-1.02 0.064 0.85 0.58-1.25 0.414
Dietary fiber <6 g/day
For 100 mg/day increase 0.98 0.94-1.02 0.308 0.99 0.95-1.03 0.601 0.97 0.93-1.03 0.330
For 1000 mg/day increase 0.80 0.52-1.23 0.308 0.89 0.57-1.38 0.601 0.77 0.46-1.29 0.330
<= 1000 mg/day 1 (ref) 1 (ref) 1 (ref)
>1000 mg/day 0.96 0.62-1.48 0.844 0.99 0.63-1.54 0.951 0.95 0.59-1.53 0.826
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Table 3 Calcium intake and odds ratio for colorectal cancer, colon cancer and rectal cancer (Continued)
Dietary fiber > =6 g/day
For 100 mg/day increase 0.92 0.85-0.996 0.039 0.92 0.85-1.00 0.051 0.91 0.83-1.01 0.066
For 1000 mg/day increase 0.43 0.19-0.96 0.039 0.45 0.20-1.004 0.051 0.41 0.16-1.06 0.066
<= 1000 mg/day 1 (ref) 1 (ref) 1 (ref)
>1000 mg/day 0.61 0.33-1.11 0.107 0.62 0.34-1.15 0.128 0.57 0.27-1.20 0.138
Model 1 –univariable logistic regression.
Model 2 –adjusted for age, gender, education.
Model 3 –adjusted for covariates from Model 2 and fish consumption [servings/week], fruit, raw and cooked vegetable consumption [servings/day], fiber [g/day],
vitamin C [mg/day], dietary iron [<=14,03 mg/day; >14,03 mg/day], alcohol consumption [g/week], adult lifetime recreational physical activity [METs-h/week],
BMI [kg/m2], smoking [current, ex-smokers, non-smokers], taking mineral supplements [yes/no].
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colorectal cancer with the increase of calcium and fiber
intake. These results were strengthen for colon cancer,
and the effect was not proven for rectal cancer.
In our study, we decided to investigate the role of rela-
tively high amount of dietary calcium. Our decision was
driven by the results of other studies showing the decrease
of the CRC risk among individuals with the highest level
of consumption (the ATBC study: >1789 mg/d RR = 0.6
[32]; the BCDDP study: >830 vs. <412 mg/day RR = 0.62
for colon but not for rectum) [33] and among patients tak-
ing supplements of 1200–2000 mg/d [34] or among these
with high total calcium intake (>1270 vs. <472 mg/day,
RR = 0.69 for colon) [33]. Some beneficial effect was also
suggested by preliminary results of our study [35,36].
Thus, our results are consistent with these findings, and,
similar to other studies, in our investigation the beneficial
effect and an interaction was not observed for lower doses
of dietary calcium. Besides, we have tried to verify the ef-
fect of vitamins, however our results were not consistent
and partially insignificant [36].
An additional benefit of our study is the investigation of
interaction effect between calcium and fiber. Both fiber
and calcium intake have shown beneficial effect and con-
siderable decrease of colon cancer risk. The benefit wasTable 4 Calcium-fiber interplay in the risk of colorectal cance
Fiber Calcium <1000 mg/d
<6 g/d 1 (ref.)
6-8 g/d CRC: 0.58 (0.34-0.99)
CC: 0.60 (0.31-1.19)
RC: 0.60 (0.31-1.17)
>8 g/d CRC: 0.44 (0.20-0.98)
CC: 0.47 (0.17-1.30)
RC: 0.47 (0.17-1.30)
Stratum specified odds ratios with 95% confidence intervals for multivariable logist
intake) and effect modifier (fiber intake).
*- adjusted for age [years], gender, education, fish consumption [servings/week], fru
vitamin C [mg/day], dietary iron [<=14,03 mg/day; >14,03 mg/day], alcohol consum
BMI [kg/m2], smoking [current, ex-smokers, non-smokers], taking mineral supplemenot proven for rectal cancer. On the basis of the available
data we were not able to distinguish if the lack of signifi-
cance was a result of either the consequence of the sample
size in relation to the smaller effect or the fact that there is
no association for this cancer site. However, the benefit
was observed when colon and rectal cancers were ana-
lyzed together.
The reason why dietary calcium may provide additional
benefit when added to fiber is that there are different
physiological functions of both dietary items. Protective
effect of dietary fiber is explained by its role of bulking up
the stool, there diluting carcinogens [37], by speeding up
transit time of the bolus [38] and decreasing contact time
between carcinogens and the large bowel [39]. Moreover,
fiber has been postulated to bind to and to dilute (and
thus to inactivate) carcinogens [40]. Additionally, fermen-
tation of fiber leads to the production of short chain fatty
acids which were observed to promote cell differentiation
or induce apoptosis [41]. Dietary fiber is also closely asso-
ciated with other potentially protective dietary items like
antyoxidative vitamins and minerals because all of them
are consumed as fruits and vegetables.
The role of calcium has also been investigated inten-
sively so far. It has been observed that an intake of calcium
increases the formation of insoluble calcium-phosphate-r (CRC), colon cancer (CC) and rectal cancer (RC)
1000-2000 mg/d >2000 mg/d
CRC: 0.55 (0.38-0.78) CRC: 0.39 (0.22-0.71)
CC: 0.47 (0.29-0.74) CC: 0.28 (0.13-0.62)
RC: 0.65 (0.41-1.01) RC: 0.54 (0.26-1.12)
CRC: 0.42 (0.24-0.73) CRC: 0.30 (0.15-0.61)
CC: 0.36 (0.18-0.74) CC: 0.22 (0.09-0.55)
RC: 0.50 (0.25-1.02) RC: 0.42 (0.17-1.03)
CRC: 0.32 (0.14-0.71) CRC: 0.23 (0.09-0.56)
CC: 0.28 (0.10-0.78) CC: 0.17 (0.05-0.54)
RC: 0.39 (0.14-1.07) RC: 0.32 (0.10-1.02)
ic regression* which include interaction terms between the exposure (calcium
it, raw and cooked vegetable consumption [servings/day], fiber [g/day],
ption [g/week], adult lifetime recreational physical activity [METs-h/week],
nts [yes/no].
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of soluble fatty acids and decreases lytic activity of fecal
water [42]. Calcium is also suspected to promote differen-
tiation and restraining growth of colonic cells through
intracellular release of calcium, calmodulin activation and
phosphorylation of intracellular enzymes [43].
The point requiring elucidation is how fiber and diet-
ary calcium may additionally interplay and decrease the
risk of colon cancer. One possible explanation is fiber’s
role in the absorption of calcium, which increases with
the decrease of pH [44]. Fiber as a source of short chain
fatty acids decreases the pH of feces [45] and thus may
increase absorption of calcium. Serum calcium, however,
is strictly regulated by homeostatic regulation [46], and
consequently, it is less likely that the beneficial effect of
dietary calcium depends on the serum concentration.
Nevertheless, it was found that calcium may act through
the activation of calcium-sensing receptors present on
the luminal surface of intestinal epithelial cells [47].
Their activation can influence cell differentiation [48].
Finally, all together, may explain the presence of modifi-
cation effect between calcium and fiber.
There is limited number of published data showing an
interaction between intake of dietary fiber and calcium
and study results are inconsistent, as some early investi-
gations provided insignificant results [49,50]. Later, the
Wheat Bran Fiber (WBF) Study –an over 36 months of
follow-up trial of cereal fiber supplements, showed, that
an inverse association between total calcium intake and
a risk of the occurrence of colorectal adenomas was
stronger in the low fiber than in the high fiber group
[51]. In the European Cancer Prevention Organization
(ECP) Intervention Study -a randomized intervention
trial of calcium and fiber supplementation, significant
interaction between the level of baseline dietary calcium
and fiber supplementation was observed in the fiber arm
(however with increased risk of adenoma recurrence
among these who consumed more dietary calcium). On
the contrary, among those who consumed more dietary
fiber at baseline and were in the calcium arm in the
aforementioned study, a decreased (though insignificant)
risk was observed [51]. The beneficial effect of both
calcium and fiber was observed in the Calcium Polyp
Prevention Study, as among individuals in the third
tertile of consumption of dietary fiber the supplementa-
tion of 1200 mg/day of calcium showed 42% decrease of
tubular adenoma risk when they were compared to the
placebo group [52].
Our results are strengthened by our relatively large sam-
ple size, the ability to perform analyses in subgroups of
colon and rectal cancer cases, a detailed assessment of
dietary habits and a possibility to take into account several
covariates. But, there are also some features requiring con-
sideration. One is the role of vitamin D. Research hasshown an inverse association between intake of vitamin D
and CRC risk [53,54]. In our study we were not able to in-
vestigate the effect of calcium across different levels of
vitamin D directly as the data about consumption of vita-
min D was not available for us. Instead of this, we had
[and adjusted for] information about the level of fish con-
sumption, the main source of dietary vitamin D in our
population (as taking supplements is very rare among
adults, except treatment for osteoporosis, but such indi-
viduals were not included into the study). Additionally, lo-
gistic regression models were adjusted for leisure time
physical activity being a surrogate of potential exposure to
sunlight UVB—a determinant of 25(OH)D.
The presented study is not free from any limitations.
One is the possible effect of supplementary calcium.
According to the protocol, only information about gen-
eral mineral supplementation was available. This was
relatively rare, as only 14.5% took mineral supplements
and sub-group analyses performed only among individ-
uals who reported no mineral supplement use, didn’t in-
fluence final results. Another possible covariate we were
not able to account for was taking NSAIDs (non-steroid
anti-inflammatory drugs). Moreover, the retrospective
design may be associated with bias—especially recall bias
and selection bias. To minimize an effect of health con-
ditions on the reported diet we asked about dietary
habits 5 years before the presence of gastrointestinal
symptoms (among cases) or before the diagnosis (among
controls). Thus, we think that even if the effect of mem-
ory degradation and imperfect recall decreased the
power of our study, our results shouldn’t be considerably
skewed. We performed our study using hospital based
controls. This may be another source of bias; however if
dietary habits among controls were worse than among
the general population of healthy adults, the observed
benefit would be higher. Additionally, interviewers were
not aware of the respondent’s diagnosis (they collect also
this information) and could make stronger the association
between calcium intake and colorectal cancer than it really
is. This is one of the main concern in case–control studies.
In our study however, interviewers were not informed of
the purpose of the study or what kind of data will be in-
vestigated further. The dietary interview consisted of 148
questions, and thus it was less likely that interviewers con-
sistently skewed (requires more details from controls)
dietary data, especially regarding items containing cal-
cium. All in all, we belief that some kind of differential
bias might exist but its effect was small.
Several molecular studies to explain the role of cal-
cium has been performed to date. Although these results
haven’t been consistent either, it was observed that the
effect of dietary calcium may depend on the genotype of
vitamin D receptor (VDR) gene. Considering poly-
morphism within start codon of VDR (FokI), the risk of
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dividuals with ff genotype and low calcium intake. This
relationship finally was alleviated by high intake of cal-
cium [55]. Research on the BsmI and poly-A VDR poly-
morphism showed significant risk reduction for rectal
cancer among individuals with SS or BB genotypes and
accompanying low calcium intake. Contrary, SS or BB
genotype individuals consuming high level of calcium
had reduced risk of colon cancer [56]. The protective ef-
fect of high dietary calcium intake for these with BB
genotype of the VDR BsmI has been also observed in
some other investigations [57]. There was also a study
on interactions between polymorphism of adenomatous
polyposis coli gene (APC), dietary calcium and fiber in-
take and CRC showing that the group of high both cal-
cium and fiber intakes was associated with about 50%
lower risk of CRC among individuals with DV or VV
genotype of APC [58]. On the whole, genetic polymor-
phisms might explain some differences also in our study,
however this information was not available either.
In summary, our study confirmed the protective effect
of higher doses of dietary calcium in the risk of colon
cancer. This relationship was observed across different
levels of dietary fiber, and the beneficial effect of dietary
calcium depended on the level of dietary fiber suggesting
modification effect of calcium and fiber. Further efforts
are needed to prove this association, and also across
higher levels of dietary fiber intake.
Conclusions
1. The study confirmed beneficial effect of calcium
consumption in the protection of colon cancer. The
benefit was not confirmed for rectal cancer.
2. The protective effect was dependent on dosage, and
was more clearly observed among individuals with
dietary calcium over 1000 mg/day.
3. The study suggests that intake of calcium may be an
effect modifier in the relationship between fiber
consumption and the development of CRC.
4. The results support other evidence for the potential
benefit of an increase of consumption of food reach
in both calcium and fiber.
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